KLRK1 and esophageal squamous cell carcinoma: Our findings suggest that NKG2D CAR-T cells in combination with radiotherapy offer a potentially curative therapeutic approach for ESCC patients, especially those who are unable to undergo resection or full-dose radiotherapy.